Bridgewater Associates’s Inogen INGN Stock Holding History

Bridgewater Associates’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,286	Closed	-$1.52M	–	738
2021 Q2	$1.52M	Buy	+23,286	New	+$1.47M	0.01%	533

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bridgewater Associates's INGN Position: Q3 2021 in Review

Bridgewater Associates sold out of Inogen (INGN) in Q3 2021, closing a stake of 23,286 shares — an estimated $1.52M sold.

Bridgewater Associates first reported a position in INGN in Q2 2021 and held it in 1 quarter. The position peaked at $1.52M in Q2 2021. 170 funds tracked by Wall St. Rank hold INGN as of Q3 2021.

Bridgewater Associates reported no remaining Inogen position as of Q3 2021 after selling out during the quarter.
Bridgewater Associates sold 23,286 Inogen shares in Q3 2021, an estimated $1.52M.
Bridgewater Associates first reported a position in Inogen in Q2 2021 and held it in 1 quarter.
Bridgewater Associates's Inogen position peaked at $1.52M in Q2 2021.
170 funds tracked by Wall St. Rank held Inogen as of Q3 2021.

Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.